Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Sectors  >  Healthcare

News : Sectors

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors
08/25MORPHOSYS : Downgraded to Neutral by Independant Research
MD
08/25FTSE 100 pulled down by miners, glum retail sales data
RE
08/25Oxford coronavirus vaccine data could go to regulators this year
RE
08/25Dow Index Swaps Out Blue Chips -- WSJ
DJ
08/25AstraZeneca starts trial of COVID-19 antibody treatment
RE
08/25ASTRAZENECA : Begins Phase 1 Trial of Potential Covid-19 Antibody Treatment
DJ
08/25Asian stocks boosted by fresh U.S.-China trade hopes
RE
08/25PHILIPS NV : Credit Suisse reiterates its Neutral rating
MD
08/25Asian stocks boosted by fresh U.S.-China trade hopes
RE
08/25FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Credit Suisse gives a Neutral rating
MD
08/25AstraZeneca starts trial of COVID-19 antibody treatment
RE
08/24Asian stocks near 2-year high as virus treatment hopes lift mood
RE
08/24Salesforce to replace Exxon in Dow Jones Industrial Average index next week
RE
08/24Salesforce, Amgen, Honeywell to Join Dow Jones Industrial Average -- Update
DJ
08/24Salesforce, Amgen and Honeywell Shares Rise After Hours on Dow Industrials Inclusion
DJ
Discover
08/24Wall Street rides bull market momentum, S&P, Nasdaq on course for new highs
RE
08/24Biotech Startup Yumanity Sets Reverse Merger With Proteostasis
DJ
08/24Moderna, EU conclude advanced talks to supply COVID-19 vaccine candidate
RE
08/24Sulzer buys self-injection pen maker to bolster under-pressure applicators unit
RE
08/24Catalent to make drug substance for AstraZeneca's COVID-19 vaccine candidate
RE
08/24DANAHER : Beckman Coulter Unit to Ship New SARS-CoV-2 Antibody Test
DJ
08/24S&P 500, Nasdaq set to hit new highs on COVID-19 treatment hopes
RE
08/24ASTRAZENECA : Catalent to make active ingredient for AstraZeneca's COVID-19 vaccine candidate
RE
08/24BAYER : One Drop Agree to Digital Health Products Development Deal
DJ
08/24BRISTOL MYERS SQUIBB : to Buy Protein-Engineering Company Forbius
DJ
08/24BAYER AG : UBS reiterates its Buy rating
MD
08/24BAYER AG : Gets a Buy rating from DZ Bank
MD
08/24PT KALBE FARMA TBK : Kalbe Farma Considers IPO for Food Unit, Bloomberg Reports
DJ
08/24Takeda to sell Japan consumer health unit valued at $2.3 billion to Blackstone
RE
08/24MERCK KGAA : Goldman Sachs reiterates its Sell rating
MD
08/24FTSE 100 rises on virus treatment hopes; AstraZeneca boosts
RE
08/24ECKERT & ZIEGLER : Receives a Buy rating from Hauck & Aufhauser
MD
08/24FACTBOX-China's coronavirus vaccine development efforts
RE
08/24NOVARTIS : Spartalizumab Phase 3 Combi-i Trial Didn't Meet Primary Endpoint
DJ
08/24STRATEC BIOMEDICAL SYSTEMS AG : Gets a Buy rating from Deutsche Bank
MD
08/23ASTRAZENECA : WRAPUP 3-Trump hails FDA's authorization of plasma treatment for coronavirus, after slamming agency
RE
08/23ASTRAZENECA : Trump considering fast-tracking UK COVID-19 vaccine before election - FT
RE
08/23ASTRAZENECA : Trump administration considering fast-tracking UK COVID-19 vaccine before election - FT
RE
08/23ASTRAZENECA : Trump Considers Fast-Tracking UK COVID-19 Vaccine Before US Election - FT
RE
08/23ELI LILLY AND : Correction to Antibody Drugs for Covid-19 Treatment Article
DJ
08/23Antibody Drugs Advancing to Fill Covid-19 Treatment Gap
DJ
08/22INOVIO PHARMACEUTICALS : China approves human testing for coronavirus vaccine grown in insect cells
RE
08/22NOVARTIS : immuno-oncology drug candidate fails skin cancer trial
RE
08/21GILEAD : FDA could expand remdesivir use despite mixed data
RE
08/21GILEAD STUDY : remdesivir has marginal benefit for moderate COVID patients
RE
08/21SINOVAC BIOTECH : Indonesia books 50 million coronavirus vaccine doses from Sinovac
RE
08/21VERTEX PHARMACEUTICALS : Gets Europe OK for Kaftrio Combination in Cystic Fibrosis
DJ
08/21ILLUMINA : Chief Accounting Officer to Retire in April After About Three Years
DJ
08/21BAYER : Climate Targets Receive Independent Approval
DJ
08/21NOVARTIS AG : UBS reiterates its Neutral rating
MD
08/21BAYER : Settles Claims Over Birth-Control Device for $1.6 Billion
DJ
08/21NOVARTIS AG : Gets a Buy rating from Goldman Sachs
MD
08/21NOVARTIS : Multiple-Sclerosis Drug Kesimpta Gets FDA Approval
DJ
08/20FISHER & PAYKEL HEALTHCARE : Planning Mexico Facility
DJ
08/20ASTRAZENECA : Mexico to get at least 2,000 doses of Russia's Sputnik vaccine to test
RE
08/20BAYER : Settles Essure Birth-Control Litigation for $1.6 Billion
DJ
08/20BAYER : to Settle U.S. Essure Claims for Around $1.6 Billion
DJ
08/20BAYER : to pay $1.6 bln to resolve U.S. claims for Essure birth-control device
RE
08/20Novartis wins FDA approval to repurpose leukaemia drug against multiple sclerosis
RE
08/20BAYER : to pay $1.6 billion to resolve U.S. claims for Essure birth-control device
RE
08/20For Covid-19 Vaccine, J&J Plans 60,000-Subject Pivotal Trial -- Update
DJ
08/20BAYER : to pay $1.6 billion to resolve U.S. claims for Essure birth-control device
RE
08/20FRESENIUS : Helios Acquires Hospitals, Medical Centers in Germany
DJ
08/20J&J, Biotech Firm In $6.5 Billion Deal J&J Agrees to Buy Biotech Company -- WSJ
DJ
08/19ASTRAZENECA : Mexico exploring phase 3 trials of Russian coronavirus vaccine
RE
Discover
08/19Vaccine makers including Moderna must hit U.S. timing goals for full payments
RE
08/19SINOVAC BIOTECH : Bangladesh ready to trial Indian COVID-19 vaccines
RE
08/19U.S. FDA rejects BioMarin hemophilia A gene therapy, shares dive
RE
08/19REGENERON PHARMACEUTICALS : Roche, Regeneron link up to develop COVID-19 antibody cocktail
RE
08/19REGENERON PHARMACEUTICALS : Roche, Regeneron link up to develop COVID-19 antibody cocktail
RE
Prev.2  3  4  5  6   7  8  9  10  11Next